 |
|
Survival After AIDS Diagnosis in Adolescents and Adults During the Treatment Era, United States, 1984-1997
Lisa M. Lee, PhD;
John M. Karon, PhD;
Richard Selik, MD;
Joyce J. Neal, PhD;
Patricia L. Fleming, PhD
JAMA. 2001;285:1308-1315.
Context Declines in the number of acquired immunodeficiency syndrome (AIDS) deaths were first observed in 1996, attributed to improvements in antiretroviral therapy and an increase in the proportion of persons receiving therapy.
Objective To examine national trends in survival time among persons diagnosed as having AIDS in 1984-1997.
Design, Setting, and Subjects Retrospective cohort study using data from a population-based registry of AIDS cases and deaths reported in the United States.
Main Outcome Measure Months of survival after AIDS diagnosis through December 31, 1998, compared by year of diagnosis.
Results Among 394 705 persons with an AIDS-defining opportunistic illness (OI) diagnosed in 1984-1997, median survival time improved from 11 months for 1984 diagnoses to 46 months for 1995 diagnoses. Among persons with an OI diagnosed in 1996 and 1997, 67% were alive at least 36 months after diagnosis and 77% were alive at least 24 months after diagnosis, respectively. Among 296 621 AIDS cases diagnosed during 1993-1997, 65% were based on immunologic criteria and 35% on OI criteria; 80% were among men; and 42% were among non-Hispanic blacks, 40% among non-Hispanic whites, 17% among Hispanics, 1% among Asians/Pacific islanders, and less than 1% among American Indians/Alaska natives. The probability of surviving at least 24 months increased from 67% for those with immunologic diagnoses in 1993 to 90% in 1997 and from 49% for those with OI diagnoses in 1993 to 80% in 1997. Survival time increased with each year of diagnosis from 1984 to 1997 for blacks, whites, and Hispanics. The greatest annual survival gains occurred among persons receiving an AIDS diagnosis in 1995 and 1996.
Conclusions Survival time after AIDS diagnosis improved from 1984 to 1997. While AIDS incidence is declining, improved survival times present a growing public health challenge as the number of persons living with chronic human immunodeficiency virus disease/AIDS increases.
Author Affiliations: Division of HIV/AIDS Prevention—Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga.
RELATED ARTICLE
March 14, 2001
JAMA. 2001;285(10):1373-1374.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Epidemiology of Human Immunodeficiency Virus in the United States
Hariri and McKenna
Clin. Microbiol. Rev. 2007;20:478-488.
ABSTRACT
| FULL TEXT
Racial/Ethnic and Age Disparities in HIV Prevalence and Disease Progression Among Men Who Have Sex With Men in the United States
Hall et al.
Am. J. Public Health 2007;97:1060-1066.
ABSTRACT
| FULL TEXT
Characteristics of Persons With Heterosexually Acquired HIV Infection, United States 1999-2004
Espinoza et al.
Am. J. Public Health 2007;97:144-149.
ABSTRACT
| FULL TEXT
Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2005;143:55-73.
ABSTRACT
| FULL TEXT
P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy
Sankatsing et al.
Antimicrob. Agents Chemother. 2004;48:1073-1081.
FULL TEXT
Coping Effectiveness Training for Men Living With HIV: Results From a Randomized Clinical Trial Testing a Group-Based Intervention
Chesney et al.
Psychosom. Med. 2003;65:1038-1046.
ABSTRACT
| FULL TEXT
Overcoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS: "Let Me Live the Way I Want to Live, Until I Can't"
Selwyn and Forstein
JAMA 2003;290:806-814.
ABSTRACT
| FULL TEXT
Key Clinical, Ethical, and Policy Issues in the Evaluation of the Safety and Effectiveness of Solid Organ Transplantation in HIV-Infected Patients
Roland et al.
Arch Intern Med 2003;163:1773-1778.
FULL TEXT
Effectiveness of highly active antiretroviral therapy among HIV-1 infected women
Gange et al.
J. Epidemiol. Community Health 2002;56:153-159.
ABSTRACT
| FULL TEXT
Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
Hogg et al.
JAMA 2001;286:2568-2577.
ABSTRACT
| FULL TEXT
Cardiomyopathy and Encephalopathy in AIDS
ANTINORI et al.
Ann. N. Y. Acad. Sci. 2001;946:121-129.
ABSTRACT
| FULL TEXT
How Long Do I Have, Doc?
JWatch General 2001;2001:2-2.
FULL TEXT
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Rose et al.
NEJM 2001;345:1435-1443.
ABSTRACT
| FULL TEXT
|
